Citable company snapshot
Elevance Health's latest SEC-sourced 2026-03-31 period shows $50.18B in revenue and $1.76B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $50.18B | $49.75B | +0.9% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $2.09B | $309.00M | +575.1% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $1.76B | $547.00M | +222.5% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $4.33B | $84.00M | +5057.1% |
| Free Cash Flow (computed) | Mar 31, 2026 | $4.10B | $-209.00M | +2060.3% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 22, 2026; accession 0001156039-26-000043.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
